Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape. | Curr Res Immunol | 2021 | 35492399 | PubTator, text mining | PubMed |
| Chemokines in Type 1 Diabetes Mellitus. | Front Immunol | 2021 | 35242125 | PubTator, text mining | PubMed |
| Low Expression of PLAT in Breast Cancer Infers Poor Prognosis and High Immune Infiltrating Level. | Int J Gen Med | 2021 | 35221711 | PubTator, text mining | PubMed |
| Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer. | Front Med (Lausanne) | 2021 | 35178409 | PubTator, text mining | PubMed |
| Positive Correlation Between LTA Expression and Overall Immune Activity Suggests an Increased Probability of Survival in Uterine Corpus Endometrial Carcinoma. | Front Cell Dev Biol | 2021 | 35155447 | PubTator, text mining | PubMed |
| EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer. | Front Genet | 2021 | 35126464 | PubTator, text mining | PubMed |
| Gene Structure Analysis of Chemokines and Their Receptors in Allotetraploid Frog, Xenopus laevis. | Front Genet | 2021 | 35126458 | PubTator, text mining | PubMed |
| Editorial: Immune Cell Lineage Reprogramming in Cancer. | Front Immunol | 2021 | 35126385 | PubTator, text mining | PubMed |
| Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy. | Front Immunol | 2021 | 35126374 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment. | Front Immunol | 2021 | 35126365 | PubTator, text mining | PubMed |
| Identification of hub genes in gastric cancer by integrated bioinformatics analysis. | Transl Cancer Res | 2021 | 35116593 | PubTator, text mining | PubMed |
| Progesterone receptor gene serves as a prognostic biomarker associated with immune infiltration in gastric cancer: a bioinformatics analysis. | Transl Cancer Res | 2021 | 35116579 | PubTator, text mining | PubMed |
| ANKDD1A may serve as a critical gene in the immune microenvironment of breast cancer. | Transl Cancer Res | 2021 | 35116461 | PubTator, text mining | PubMed |
| Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment. | Front Immunol | 2021 | 35116045 | PubTator, text mining | PubMed |
| Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma. | Front Mol Biosci | 2021 | 35111813 | PubTator, text mining | PubMed |
| Integrative Multi-Omics Analysis Reveals Candidate Biomarkers for Oral Squamous Cell Carcinoma. | Front Oncol | 2021 | 35096593 | PubTator, text mining | PubMed |
| Prognostic and Predictive Value of BGN in Colon Cancer Outcomes and Response to Immunotherapy. | Front Oncol | 2021 | 35096572 | PubTator, text mining | PubMed |
| Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment. | Front Pharmacol | 2021 | 35095530 | PubTator, text mining | PubMed |
| Identification of TRPM2 as a Marker Associated With Prognosis and Immune Infiltration in Kidney Renal Clear Cell Carcinoma. | Front Mol Biosci | 2021 | 35071322 | PubTator, text mining | PubMed |
| EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma. | Front Immunol | 2021 | 35069551 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=40